Garber Alan M — SEC insider filings

SEC reporting owner CIK 1312907. 16 insider filings on record with FilingPulse; latest filed 2026-10-19.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2021-03-17 to 2026-10-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
EXELIXIS, INC. (EXEL)Director7—4 legs · 120,506 sh · $2,552,03311
VERTEX PHARMACEUTICALS INC / MA (VRTX)Director9——12

Insider filings — Garber Alan M

FiledFormIssuerReported transactionsSource
2026-10-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 29.27 (derivative) @ $512.44EDGAR
2026-07-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 31.56 (derivative) @ $475.28EDGAR
2026-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 472 @ $0 · Grant/award (A): 1,433 (derivative) @ $0EDGAR
2026-04-174VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 33.90 (derivative) @ $442.50EDGAR
2025-05-054VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 398 @ $0 · Grant/award (A): 1,199 (derivative) @ $0EDGAR
2024-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 3,142 (derivative) @ $0EDGAR
2024-03-254EXELIXIS, INC. (EXEL)Option exercise (M): 23,491 @ $19.57 · Sale (S): 19,205 @ $24.01 · Option exercise (M): 23,491 (derivative) @ $0EDGAR
2023-06-024EXELIXIS, INC. (EXEL)Grant/award (A): 44,087 (derivative) @ $0EDGAR
2023-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 584 @ $0 · Grant/award (A): 1,741 (derivative) @ $0EDGAR
2023-02-234EXELIXIS, INC. (EXEL)Option exercise (M): 40,000 @ $6.30 · Sale (S): 40,000 @ $17.49 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2022-05-274EXELIXIS, INC. (EXEL)Grant/award (A): 42,422 (derivative) @ $0EDGAR
2022-05-034VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 4,462 (derivative) @ $0EDGAR
2022-03-034EXELIXIS, INC. (EXEL)Option exercise (M): 40,000 @ $3.13 · Sale (S): 21,301 @ $21 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2021-05-284EXELIXIS, INC. (EXEL)Grant/award (A): 33,549 (derivative) @ $0EDGAR
2021-05-044VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 6,067 (derivative) @ $0EDGAR
2021-03-174EXELIXIS, INC. (EXEL)Option exercise (M): 40,000 @ $3.38 · Sale (S): 40,000 @ $23.60 · Option exercise (M): 40,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1312907 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs